Aflac Incorporated

(New York Stock Exchange)
Slightly Bullish +15

Aflac stock: Mizuho raises target as Q3 outlook stays mixed

πŸ“ˆ Mizuho raised Aflac's price target to $112 from $107 following Q3 results and higher earnings assumptions.

πŸ“‰ The analyst retained an Underperform rating due to uneven premium trends and reliance on capital deployment for growth.

πŸ‡ΊπŸ‡Έ U.S. pretax adjusted earnings surged 31.5% to $493 million in the third quarter, outpacing Japan's decline.

πŸ‡―πŸ‡΅ Japan pretax adjusted earnings dropped 21.0% to $961 million as new premium equivalents continue to shrink.

πŸ’° Aflac released approximately $1 billion in capital via a cession of cancer reserves to Aflac Re Bermuda.

πŸ“Š Reported net income was sharply lower due to portfolio repositioning losses, though adjusted EPS hit $2.43.

πŸ’΅ The board declared a Q4 dividend of $0.61 per share, payable December 1 to shareholders of record on November 18.

πŸ”„ Aflac returned $1.1 billion total through repurchases and dividends in the third quarter.

πŸ“… Mizuho raised fiscal 2026 earnings estimates by 9% to $7.70 per share with further increases expected for 2027-2028.

πŸ“‰ Analysts anticipate modest reductions in future benefit ratios due to assumption reviews in both Japan and the U.S.

Bullish Signals
  • Mizuho raised its price target to $112 from $107, citing higher earnings estimates and capital released by a Japan reinsurance transaction.
  • U.S. pretax adjusted earnings rose 31.5% to $493 million in Q3, demonstrating strong operational performance in the American market.
  • The company declared a fourth-quarter dividend of $0.61 per share, marking the 44th consecutive year of dividend increases.
  • Aflac returned $1.1 billion through repurchases and dividends in Q3, reinforcing its commitment to capital return strategies.
  • Mizuho increased fiscal 2026 earnings estimates by 9% to $7.70 per share, with further upside projected for 2027 and 2028.
Risk Factors
  • Mizuho retained an Underperform rating due to uneven premium trends and reliance on capital deployment for future growth.
  • Japan pretax adjusted earnings fell 21.0% to $961 million in Q3 as new premium equivalents continue to shrink.
  • Portfolio repositioning losses pushed reported net income sharply lower despite solid adjusted earnings per diluted share of $2.43.
  • Analysts expect future benefit ratios to modestly reduce in both Japan and the U.S., assuming no change in business mix.
Full Analysis
Aflac Inc. received an analyst upgrade from Mizuho, which raised its price target to $112 from $107 while maintaining an Underperform rating following the company's mixed third-quarter report. The revision was driven by higher earnings estimates and capital released through a Japan reinsurance transaction, though uneven premium trends persist. Aflac reported a sharp divergence in performance between its regions during Q3, with U.S. pretax adjusted earnings rising 31.5% to $493 million while Japan pretax adjusted earnings fell 21.0% to $961 million. Portfolio repositioning losses further impacted reported net income, even as adjusted earnings per diluted share reached $2.43. The company declared a fourth-quarter dividend of $0.61 per share and returned $1.1 billion in total capital via repurchases and dividends in the third quarter. Management expects future benefit ratios to modestly reduce due to assumption reviews, while capital flexibility adds to the return case despite shrinking new premiums in Japan. Analysts project fiscal 2026 earnings of $7.70 per share, with estimates for 2027 and 2028 set at $7.65 and $8.05 respectively. The board's dividend declaration marks the 44th consecutive year of increases, highlighting a strong commitment to shareholder returns despite mixed operating trends.